Literature DB >> 17957144

Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2.

Sun-Mi Park1, Scott Shell, Amir Reza Radjabi, Robert Schickel, Christine Feig, Ben Boyerinas, Daniela M Dinulescu, Ernst Lengyel, Marcus E Peter.   

Abstract

The microRNA let-7 regulates late embryonic development by suppressing expression of a number of genes such as c-myc and RAS as well as the embryonic gene high mobility group, A2 (HMGA2). We now demonstrate that HMGA2 is more efficiently targeted by let-7 than RAS. Its expression inversely correlates with the expression of let-7 in the NCI60 cells lines, and the expression of RAS does not change when amounts of let-7 that efficiently silence expression of HMGA2 are introduced into tumor cells. We did not find a difference in the expression of HMGA2 between primary ovarian cancer samples and matching metastases, suggesting that the expression of HMGA2 represents an early event during cancer progression. The late repression of HMGA2 by let-7 during embryonic development, and the early reexpression of HMGA2 during cancer development, is in line with the hypothesis that cancer development represents a case of reverse embryogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17957144     DOI: 10.4161/cc.6.21.4845

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  101 in total

1.  Expression of high mobility group A2 is associated with poor survival in hepatocellular carcinoma.

Authors:  Lielin Wu; Zhiming Wang; Rongli Lu; Wei Jiang
Journal:  Pathol Oncol Res       Date:  2012-03-30       Impact factor: 3.201

Review 2.  MicroRNAs: novel biomarkers for gastrointestinal carcinomas.

Authors:  Li Xie; Xiaoping Qian; Baorui Liu
Journal:  Mol Cell Biochem       Date:  2010-04-27       Impact factor: 3.396

3.  MicroRNA expression profiles in Kaposi's sarcoma.

Authors:  Ana Maria Catrina Ene; Ioana Borze; Mohamed Guled; Mariana Costache; Gayle Leen; Maria Sajin; Elena Ionica; Aura Chitu; Sakari Knuutila
Journal:  Pathol Oncol Res       Date:  2013-09-13       Impact factor: 3.201

Review 4.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

Review 5.  Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs.

Authors:  Chao-Shun Yang; Tariq M Rana
Journal:  Mol Biosyst       Date:  2012-10-05

6.  Antiproliferative effect of upregulation of hsa-let-7c-5p in human acute erythroleukemia cells.

Authors:  Deniz Mortazavi; Mohammadreza Sharifi
Journal:  Cytotechnology       Date:  2018-08-02       Impact factor: 2.058

7.  Derepression of HMGA2 via removal of ZBRK1/BRCA1/CtIP complex enhances mammary tumorigenesis.

Authors:  Kazi Mokim Ahmed; Connie Y Tsai; Wen-Hwa Lee
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

Review 8.  Potential regulatory functions of microRNAs in the ovary.

Authors:  Tannaz Toloubeydokhti; Orhan Bukulmez; Nasser Chegini
Journal:  Semin Reprod Med       Date:  2008-10-24       Impact factor: 1.303

Review 9.  MicroRNAs in ovarian carcinomas.

Authors:  Neetu Dahiya; Patrice J Morin
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

10.  Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.

Authors:  Hyunsoo Kim; Wei Huang; Xiuli Jiang; Brenton Pennicooke; Peter J Park; Mark D Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.